Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes.

چکیده

A subset of eyes with neovascular AMD experience sub-optimal response to anti-VEGF therapy resulting in frequent injections. Faricimab has been used in this cohort due to reputed increased durability. Dosing strategies when switching vary, particularly regarding the need for a reloading phase. Our…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• تصویربرداری و تشخیص
• درمان های ضد VEGF
• دژنراسیون ماکولا